AAAAAA

   
Results: 1-11 |
Results: 11
P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy
Authors: Broxterman, HJ Sonneveld, P van Putten, WJL Lankelma, J Eekman, CA Ossenkoppele, GJ Pinedo, HM Lowenberg, B Schuurhuis, GJ
Citation: Hj. Broxterman et al., P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy, LEUKEMIA, 14(6), 2000, pp. 1018-1024
A mathematical model of drug transport in human breast cancer
Authors: Lankelma, J Luque, RF Dekker, H Schinkel, W Pinedo, HM
Citation: J. Lankelma et al., A mathematical model of drug transport in human breast cancer, MICROVASC R, 59(1), 2000, pp. 149-161
The effect of glutathione on the ATPase activity of MRP1 in its natural membranes
Authors: Hooijberg, JH Pinedo, HM Vrasdonk, C Priebe, W Lankelma, J Broxterman, HJ
Citation: Jh. Hooijberg et al., The effect of glutathione on the ATPase activity of MRP1 in its natural membranes, FEBS LETTER, 469(1), 2000, pp. 47-51
The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells
Authors: Wielinga, PR Westerhoff, HV Lankelma, J
Citation: Pr. Wielinga et al., The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells, EUR J BIOCH, 267(3), 2000, pp. 649-657
Evaluating limited specificity of drug pumps - Reduced relative resistancein human MDR phenotypes
Authors: Jongsma, APM Riethorst, A Lankelma, J Dekker, H Westerhoff, HV
Citation: Apm. Jongsma et al., Evaluating limited specificity of drug pumps - Reduced relative resistancein human MDR phenotypes, EUR J BIOCH, 267(17), 2000, pp. 5369-5377
Simvastatin improves disturbed endothelial barrier function
Authors: Amerongen, GPV Vermeer, MA Negre-Aminou, P Lankelma, J Emeis, JJ van Hinsbergh, VWM
Citation: Gpv. Amerongen et al., Simvastatin improves disturbed endothelial barrier function, CIRCULATION, 102(23), 2000, pp. 2803-2809
Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export
Authors: Evers, R de Haas, M Sparidans, R Beijnen, J Wielinga, PR Lankelma, J Borst, P
Citation: R. Evers et al., Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export, BR J CANC, 83(3), 2000, pp. 375-383
Doxorubicin gradients in human breast cancer
Authors: Lankelma, J Dekker, H Luque, RF Luykx, S Hoekman, K van der Valk, P van Diest, PJ Pinedo, HM
Citation: J. Lankelma et al., Doxorubicin gradients in human breast cancer, CLIN CANC R, 5(7), 1999, pp. 1703-1707
Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia
Authors: Broxterman, HJ Sonneveld, P Pieters, R Lankelma, J Eekman, CA Loonen, AH Schoester, M Ossenkoppele, GJ Lowenberg, B Pinedo, HM Schuurhuis, GJ
Citation: Hj. Broxterman et al., Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia, LEUKEMIA, 13(2), 1999, pp. 258-265
In vitro transepithelial drug transport by on-line measurement: Cellular control of paracellular and transcellular transport
Authors: Wielinga, PR De Waal, E Westerhoff, HV Lankelma, J
Citation: Pr. Wielinga et al., In vitro transepithelial drug transport by on-line measurement: Cellular control of paracellular and transcellular transport, J PHARM SCI, 88(12), 1999, pp. 1340-1347
Potent interaction of flavopiridol with MRP1
Authors: Hooijberg, JH Broxterman, HJ Scheffer, GL Vrasdonk, C Heijn, M de Jong, MC Scheper, RJ Lankelma, J Pinedo, HM
Citation: Jh. Hooijberg et al., Potent interaction of flavopiridol with MRP1, BR J CANC, 81(2), 1999, pp. 269-276
Risultati: 1-11 |